Related Experiment Video
Updated: Aug 16, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Anti-N-methyl-D-aspartate receptor encephalitis with concurrent human herpes virus-6A deoxyribonucleic acid
Sho Shimohama1, Takahiro Iizuka2, Tsubasa Takizawa1
1Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
Abstract:
We report an autopsy case of anti-N-methyl-D-aspartate (NMDA) receptor (NMDAR) encephalitis with concurrent human herpes virus-6 (HHV-6) A deoxyribonucleic acid (DNA) detection in cerebrospinal fluid (CSF). A 38-year-old previously healthy Japanese man presented with a generalized seizure. Brain magnetic resonance imaging (MRI) findings were unremarkable, but CSF revealed pleocytosis. On Day 11, HHV-6 DNA was detected in CSF, and IgG antibodies against the NR1 subunit of the NMDAR (GluN1) were subsequently detected. Since HHV-6 encephalitis was initially suspected, the patient was treated with foscarnet and ganciclovir, but the HHV-6A copy number increased from 200 (Day 22) to 2000 copies/mL (Day 47), and the therapy was ineffective. As typical symptoms of anti-NMDAR encephalitis developed, we changed the patient's treatment to combat anti-NMDAR encephalitis. He was repeatedly treated with first-line immunotherapy, and GluN1 antibody titer decreased. He was not treated with second-line immunotherapy because of recurrent infections; he died on Day 310. Postmortem examinations did not show systemic tumors. Microscopic examination of the brain revealed only severe neuronal rarefaction in the hippocampal cornu ammonis (CA) 3-4 areas with gliosis. Early initiation of aggressive immunotherapy may be required in a refractory case of anti-NMDAR encephalitis, even with HHV-6A DNA detection, because the significance of this concurrent detection in autoimmune encephalitis remains unclear.
Insights
This case study highlights anti-N-methyl-D-aspartate receptor encephalitis with concurrent human herpes virus-6 detection. Aggressive immunotherapy may be crucial even with HHV-6 DNA, as its role in autoimmune encephalitis remains unclear.
Area of Science:
- Neurology
- Immunology
- Virology
Background:
- Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a severe autoimmune neurological disorder.
- Human herpes virus-6 (HHV-6) is a known neurotropic virus.
- Concurrent detection of viral DNA and autoantibodies presents diagnostic and therapeutic challenges.
Observation:
- A 38-year-old man presented with seizures and CSF pleocytosis.
- HHV-6 DNA and NMDA receptor (GluN1) antibodies were detected in CSF.
- Initial antiviral treatment for HHV-6 was ineffective, with rising viral load.
Findings:
- The patient developed typical anti-NMDA receptor encephalitis symptoms.
- Treatment with immunotherapy led to a decrease in GluN1 antibody titers.
- Despite treatment, the patient experienced recurrent infections and died.
Implications:
- The significance of concurrent HHV-6 DNA detection in anti-NMDA receptor encephalitis is unclear.
- Early and aggressive immunotherapy might be necessary in refractory cases.
- Further research is needed to understand the interplay between viral infections and autoimmune encephalitis.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Herpes
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology